Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson disease-associated cognitive impairment

Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Escherichia Coli K1-colibactin meningitis induces microglial NLRP3/IL-18 exacerbating H3K4me3-synucleinopathy in human inflammatory gut-brain axis
Van Thi Ai Tran, Xiaohui Zhu, Ariunzaya Jamsranjav, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis
Li Mao, Junli Zhang, Lianyan Jiang, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Potential Alzheimer's disease therapeutic nano-platform: Discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles
Jaehoon Kim, Hyeji Um, Na Hee Kim, et al.
Bioactive Materials (2023) Vol. 24, pp. 497-506
Open Access | Times Cited: 22
Adverse and compensatory neurophysiological slowing in Parkinson’s disease
Alex I. Wiesman, Jason da Silva Castanheira, Clotilde Degroot, et al.
Progress in Neurobiology (2023) Vol. 231, pp. 102538-102538
Open Access | Times Cited: 17
Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation
Víctor Arribas, Yara Onetti, Marina Ramiro‐Pareta, et al.
JCI Insight (2024)
Open Access | Times Cited: 7
Effects of Transcranial Direct Current Stimulation on Potential P300-Related Events and Alpha and Beta EEG Band Rhythms in Parkinson's Disease
Rosa Angela Fabio, Rossella Suriano, Antonio Gangemi
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2, pp. 25-25
Open Access | Times Cited: 6
Cascaded Deep Learning Frameworks in Contribution to the Detection of Parkinson’s Disease
Nalini Chintalapudi, Gopi Battineni, Mohammad Amran Hossain, et al.
Bioengineering (2022) Vol. 9, Iss. 3, pp. 116-116
Open Access | Times Cited: 23
Effectiveness of exergaming-based interventions for mobility and balance performance in older adults with Parkinson’s disease: systematic review and meta-analysis of randomised controlled trials
Jiaxin Zhang, Yan Luximon, Marco Y.C. Pang, et al.
Age and Ageing (2022) Vol. 51, Iss. 8
Open Access | Times Cited: 21
Lifetime air pollution exposure, cognitive deficits, and brain imaging outcomes: A systematic review
Aurora Yuan, Olivia M. Halabicky, Hengyi Rao, et al.
NeuroToxicology (2023) Vol. 96, pp. 69-80
Open Access | Times Cited: 11
Speech dysfunction, cognition, and Parkinson's disease
Andrea Rohl, Stephanie Gutierrez, Karim Johari, et al.
Progress in brain research (2022), pp. 153-173
Closed Access | Times Cited: 16
Trajectories and contributing factors of neural compensation in healthy and pathological aging
Nico Bunzeck, Tineke K. Steiger, Ulrike M. Krämer, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 156, pp. 105489-105489
Open Access | Times Cited: 9
Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease
Peter S. Myers, John O’Donnell, Joshua J. Jackson, et al.
Neurology (2022) Vol. 99, Iss. 1
Open Access | Times Cited: 15
Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
Chariklia Chatzaki, Vasileios Skaramagkas, Zinovia Kefalopoulou, et al.
Sensors (2022) Vol. 22, Iss. 24, pp. 9937-9937
Open Access | Times Cited: 15
Plasma mir-203a-3p as a Novel Diagnostic Biomarker in Patients with Parkinson’s Disease Dementia
Ya-Fang Hsu, Shau‐Ping Lin, Yung‐Tsai Chu, et al.
(2024)
Open Access | Times Cited: 2
Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes
Angeliki Zarkali, Naomi Hannaway, Peter McColgan, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 2
Predicting the occurrence of mild cognitive impairment in Parkinson’s disease using structural MRI data
Iman Beheshti, Ji Hyun Ko
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson's Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder
Daniel Dautan, Wojciech Pasławski, Sergio Montejo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Neuroprotective effects of phlorotannins: Biochemical and molecular mechanisms of antineuroinflammatory activities and memory-enhancing effects
Tosin A. Olasehinde, Chijioke Olisah, Ademola O. Olaniran
Studies in natural products chemistry (2024), pp. 115-132
Closed Access | Times Cited: 2
Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers
Arman Gorji, Ali Fathi Jouzdani
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304355-e0304355
Open Access | Times Cited: 2
The potential of arts therapies in Parkinson's disease rehabilitation: A comprehensive review
Yiyuan Li, Xuexing Luo, Aijia Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35765-e35765
Open Access | Times Cited: 2
Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model
Eleonora Fiorenzato, Simone Cauzzo, Luca Weis, et al.
Journal of the Neurological Sciences (2024) Vol. 466, pp. 123283-123283
Closed Access | Times Cited: 2
Global, Regional, and National Burden of Parkinson's Disease 1990–2021: A Systematic Analysis of the Global Burden of Disease Study 2021
Jiacheng Wang, Shuhao Zhang, Linna Yuan, et al.
(2024)
Open Access | Times Cited: 2
The Potential of Arts Therapies in Parkinson's Disease Rehabilitation: A Comprehensive Review
Yiyuan Li, Xuexing Luo, Aijia Zhang, et al.
(2024)
Closed Access | Times Cited: 1
Hybrid Grey Wolf and Whale Optimization for Enhanced Parkinson's Prediction Based on Machine Learning Models Using Biomedical Sound
Hazem Al‐Najjar, Nadia Al‐Rousan, Dana Al-Najjar
Informatics in Medicine Unlocked (2024) Vol. 48, pp. 101524-101524
Open Access | Times Cited: 1
The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
Kelsey Bernard, J A Mota, Paige V Wene, et al.
Experimental Neurology (2024) Vol. 381, pp. 114926-114926
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top